万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>肿瘤学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生3>>医学(研究与实验)

Clinical and Translational Medicine《临床与转化医学》 (官网投稿)

简介
  • 期刊简称CLIN TRANSL MED
  • 参考译名《临床与转化医学》
  • 核心类别 SCIE(2024版), 知网外文库,外文期刊,
  • IF影响因子
  • 自引率2.50%
  • 主要研究方向医学-MEDICINE, RESEARCH & EXPERIMENTAL医学:研究与实验;ONCOLOGY肿瘤学

主要研究方向:

等待设置主要研究方向
医学-MEDICINE, RESEARCH & EXPERIMENTAL医学:研究与实验;ONCOLOGY肿瘤学

Clinical and Translational Medicine《临床与转化医学》(月刊). Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access&n...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:

https://onlinelibrary.wiley.com/journal/20011326

3、投稿网址:https://mc.manuscriptcentral.com/ctm2

4、官网邮箱:office@ctmworld.org

5、期刊刊期:月刊,一年出版12期。

2022117日星期一

                              

 

投稿须知【官网信息】

 

Clinical and Translational Medicine

Author Guidelines

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/ctm2.

Click here for more details on how to use ScholarOne.

Data protection:

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

2. AIMS AND SCOPE

Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal is focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.

The journal covers all areas of clinical and translational medicine (CTM) but specializes in several Themed Collections:

Education and Career Development

Clinical Studies of Drugs and Devices

Target-Based Drug Discovery and Development

Clinical Bioinformatics

Clinical Trans-omics

Single-cell Biomedicine

Stem Cell Biology and Therapy

Clinical Genomics

Vaccines and Immunotherapy

Chronic Metabolic Diseases

Please find the detailed description of the themed collections here.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Original Research Article

Review Article

Commentary

Editorial

Short Communication

Letter to Editor

Please refer to the page here for detailed requirements of each type of article.

4. PREPARING THE SUBMISSION

Cover letters

A cover letter is required, including the following information:

An explanation of why your manuscript should be published in Clinical and Translational Medicine

An explanation of any issues relating to journal policies

A declaration of any potential competing interests

Confirmation that all authors have approved the manuscript for submission

Confirmation that the content of the manuscript has not been published, or submitted for publication elsewhere (see our Duplicate publication policy)

If you are submitting a manuscript to a particular special issue, please refer to its specific name in your covering letter

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/20011326/homepage/author-guidelines


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭